A circadian rhythm-related lncRNA signature correlates with prognosis and tumor immune microenvironment in head and neck squamous cell carcinoma

被引:1
|
作者
Zheng, Hongyu [1 ]
Li, Qiuyue [2 ]
Yang, Kai [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, 1 Youyi Rd, Chongqing 400016, Peoples R China
[2] Tianjin Med Univ, Hosp 2, Dept Emergency Med, 23 Pingjiang Rd, Tianjin 300211, Peoples R China
关键词
Circadian rhythm; lncRNA; Squamous cell carcinoma; Prognostic signature; Immune microenvironment; PROGRESSION; CANCER;
D O I
10.1007/s12672-024-01181-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveTo investigate circadian rhythm-associated long non-coding RNA (lncRNA) signatures in predicting prognosis, metabolism, and immune infiltration in Head and Neck Squamous Cell Carcinoma (HNSC).MethodsHNSC samples were collected from the TCGA database. A signature was constructed using Cox regression and Least Absolute Shrinkage and Selection Operator (LASSO) methods. The immune cell infiltration was analyzed using CIBERSORT, ssGSEA, and MCPcounter. The RT-qPCR was used to detect the expression of signature lncRNAs.ResultsA signature comprising 8 lncRNAs was constructed. The constructed signature demonstrated good prognostic prediction capability for HNSC. A nomogram encompassing risk score accurately predicted the long-term OS probability of HNSC. The infiltration levels of T cell, B cell and Macrophages were significantly higher in the high-risk group than in the low-risk group. Cluster analysis showed that the signature lncRNAs could classify the HNSC samples into two clusters. The RT-qPCR suggested that the expression of lncRNAs in signature was consistent with the data in TCGA.ConclusionThe circadian rhythm-associated lncRNA signature has potential as a prognostic indicator for HNSC. It exhibits associations with metabolism, immune microenvironment, and drug sensitivity, thereby providing valuable insights for informing the treatment of HNSC.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Advances in tumor immune microenvironment of head and neck squamous cell carcinoma: A review of literature
    Hong, Qichao
    Ding, Shun
    Xing, Chengliang
    Mu, Zhonglin
    MEDICINE, 2024, 103 (09) : E37387
  • [32] Effects of Tobacco Smoking on the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
    de la Iglesia, Janis V.
    Slebos, Robbert J. C.
    Martin-Gomez, Laura
    Wang, Xuefeng
    Teer, Jamie K.
    Tan, Aik Choon
    Gerke, Travis A.
    Aden-Buie, Garrick
    van Veen, Tessa
    Masannat, Jude
    Chaudhary, Ritu
    Song, Feifei
    Fournier, Michelle
    Siegel, Erin M.
    Schabath, Matthew B.
    Wadsworth, J. Trad
    Caudell, Jimmy
    Harrison, Louis
    Wenig, Bruce M.
    Conejo-Garcia, Jose
    Hernandez-Prera, Juan C.
    Chung, Christine H.
    CLINICAL CANCER RESEARCH, 2020, 26 (06) : 1474 - 1485
  • [33] Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma
    Mito, Ikko
    Takahashi, Hideyuki
    Kawabata-Iwakawa, Reika
    Ida, Shota
    Tada, Hiroe
    Chikamatsu, Kazuaki
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [34] An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma
    Qian, Lvsheng
    Ni, Tingting
    Fei, Bing
    Sun, Hui
    Ni, Haosheng
    BMC CANCER, 2022, 22 (01)
  • [35] Immune microenvironment of human papillomavirus-positive head and neck squamous cell carcinoma
    Zhu, Dong
    He, Xiang
    Li, Yu
    Li, Guoping
    Chen, Min
    SCIENCE PROGRESS, 2024, 107 (01)
  • [36] Identification of the Immune-Related Genes in Tumor Microenvironment That Associated With the Recurrence of Head and Neck Squamous Cell Carcinoma
    Liu Chengcheng
    Qi Wenwen
    Gong Ningyue
    Zhu Fangyuan
    Xu Runtong
    Teng Zhenxiao
    Xu Fenglei
    Qin Yiming
    Zhao Miaoqing
    Li Xiaoming
    Xia Ming
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [37] Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional Therapeutics
    Miyauchi, Sayuri
    Kim, Sangwoo S.
    Pang, John
    Gold, Kathryn A.
    Gutkind, J. Silvio
    Califano, Joseph A.
    Mell, Loren K.
    Cohen, Ezra E. W.
    Sharabi, Andrew B.
    CLINICAL CANCER RESEARCH, 2019, 25 (14) : 4211 - 4223
  • [38] Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma
    Ju, Lincheng
    Shi, Yaxing
    Liu, Gang
    PEERJ, 2022, 10
  • [39] Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma
    Wang, Jian
    Bian, Qinjiang
    Liu, Jialin
    Moming, Adili
    BIOENGINEERED, 2021, 12 (02) : 10049 - 10062
  • [40] Understanding the tumor microenvironment in head and neck squamous cell carcinoma
    Rad, Habib Sadeghi
    Shiravand, Yavar
    Radfar, Payar
    Ladwa, Rahul
    Perry, Chris
    Han, Xiaoyuan
    Warkiani, Majid Ebrahimi
    Adams, Mark N.
    Hughes, Brett G. M.
    O'Byrne, Ken
    Kulasinghe, Arutha
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2022, 11 (06)